As the federal health emergency ended May 11 and COVID numbers are on the rise, here’s how you can still access tests, at-home and PCR. (Michael Bocchieri/Getty Images) It’s that time again: COVID-19 ...
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
COVID cases are starting to creep up again in the U.S., and it’s understandable to have new questions about the virus and the newest CDC guidance on isolation after a positive test. After all, it’s ...
Health and Me on MSN
WHO approves two COVID-19 rapid antigen tests, check the details here
SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...
A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...
Zacks Investment Research on MSN
CODX shares dip despite Australian patent grant for Co-Dx PCR platform
CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results